Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atorvastatin +/- torcetrapib in patients with coronary artery disease

Trial Profile

Atorvastatin +/- torcetrapib in patients with coronary artery disease

Phase of Trial: Phase II

Latest Information Update: 01 Oct 2013

At a glance

  • Drugs Torcetrapib (Primary) ; Atorvastatin
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Oct 2013 New trial record
    • 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top